Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma

被引:114
作者
Kudo, Masatoshi [1 ]
机构
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osaka 5898511, Japan
关键词
MOLECULAR TARGETED AGENTS; PHASE-III; TRANSARTERIAL CHEMOEMBOLIZATION; DOUBLE-BLIND; OPEN-LABEL; SORAFENIB; TRIAL; RESISTANCE; SURVIVAL; THERAPY;
D O I
10.1159/000487148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 19
页数:19
相关论文
共 60 条
[1]  
Abou- Alfa GK, 2018, J CLIN ONCOL S4S, V36, pA207
[2]   Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma [J].
Arizumi, Tadaaki ;
Ueshima, Kazuomi ;
Takeda, Haruhiko ;
Osaki, Yukio ;
Takita, Masahiro ;
Inoue, Tatsuo ;
Kitai, Satoshi ;
Yada, Norihisa ;
Hagiwara, Satoru ;
Minami, Yasunori ;
Sakurai, Toshiharu ;
Nishida, Naoshi ;
Kudo, Masatoshi .
JOURNAL OF GASTROENTEROLOGY, 2014, 49 (12) :1578-1587
[3]   Modes of resistance to anti-angiogenic therapy [J].
Bergers, Gabriele ;
Hanahan, Douglas .
NATURE REVIEWS CANCER, 2008, 8 (08) :592-603
[4]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[5]   Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial [J].
Cainap, Calin ;
Qin, Shukui ;
Huang, Wen-Tsung ;
Chung, Ik Joo ;
Pan, Hongming ;
Cheng, Ying ;
Kudo, Masatoshi ;
Kang, Yoon-Koo ;
Chen, Pei-Jer ;
Toh, Han-Chong ;
Gorbunova, Vera ;
Eskens, Ferry A. L. M. ;
Qian, Jiang ;
McKee, Mark D. ;
Ricker, Justin L. ;
Carlson, Dawn M. ;
El-Nowiem, Saied .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (02) :172-U77
[6]   FGFR4 and TGF-β1 Expression in Hepatocellular Carcinoma: Correlation with Clinicopathological Features and Prognosis [J].
Chen, Zhixin ;
Xie, Bao ;
Zhu, Qinhua ;
Xia, Qinghai ;
Jiang, Songmin ;
Cao, Ruoyu ;
Shi, Lihua ;
Qi, Dansi ;
Li, Xiaokun ;
Cai, Lin .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2013, 10 (13) :1868-1875
[7]   Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Lin, Deng-Yn ;
Park, Joong-Won ;
Kudo, Masatoshi ;
Qin, Shukui ;
Chung, Hyun-Cheol ;
Song, Xiangqun ;
Xu, Jianming ;
Poggi, Guido ;
Omata, Masao ;
Lowenthal, Susan Pitman ;
Lanzalone, Silvana ;
Yang, Liqiang ;
Lechuga, Maria Jose ;
Raymond, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4067-+
[8]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[10]   Transarterial Chemoembolization Can Be Safely Performed in Patients with Hepatocellular Carcinoma Invading the Main Portal Vein and May Improve the Overall Survival [J].
Chung, Goh Eun ;
Lee, Jeong-Hoon ;
Kim, Hwi Young ;
Hwang, Sang Youn ;
Kim, Joon Suk ;
Chung, Jin Wook ;
Yoon, Jung-Hwan ;
Lee, Hyo-Suk ;
Kim, Yoon Jun .
RADIOLOGY, 2011, 258 (02) :627-634